The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part D price negotiation, part of the ...
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...
U.S. division has sued CMS over the Medicare drug pricing negotiations policy included in the Inflation Reduction Act. In its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback